Nucleic acids encoding anti-human ανβ3 and ανβ5 antibodies
US7087405B2 · kind B2 · utility
3Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2002 |
| Grant date | Aug 8, 2006 |
| Priority date | — |
| Expiry date | Dec 13, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to novel humanized and other recombinant or engineered antibodies or monoclonal antibodies to a human αv subunit-containing heterodimeric integrin receptors and to the genes encoding same. Such antibodies are useful for the therapeutic and/or prophylactic treatment of disorders mediated by such receptors, such as cancer, in human patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.